IBDEI070 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2962,1,4,0)
 ;;=4^Z95.820
 ;;^UTILITY(U,$J,358.3,2962,2)
 ;;=^5063678
 ;;^UTILITY(U,$J,358.3,2963,0)
 ;;=Z95.828^^18^210^67
 ;;^UTILITY(U,$J,358.3,2963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2963,1,3,0)
 ;;=3^Presence of Vascular Implants & Grafts,Other
 ;;^UTILITY(U,$J,358.3,2963,1,4,0)
 ;;=4^Z95.828
 ;;^UTILITY(U,$J,358.3,2963,2)
 ;;=^5063679
 ;;^UTILITY(U,$J,358.3,2964,0)
 ;;=Z95.2^^18^210^66
 ;;^UTILITY(U,$J,358.3,2964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2964,1,3,0)
 ;;=3^Presence of Prostetic Heart Valve
 ;;^UTILITY(U,$J,358.3,2964,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,2964,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,2965,0)
 ;;=Z95.3^^18^210^68
 ;;^UTILITY(U,$J,358.3,2965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2965,1,3,0)
 ;;=3^Presence of Xenogenic Heart Valve
 ;;^UTILITY(U,$J,358.3,2965,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,2965,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,2966,0)
 ;;=I27.9^^18^210^69
 ;;^UTILITY(U,$J,358.3,2966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2966,1,3,0)
 ;;=3^Pulmonary Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,2966,1,4,0)
 ;;=4^I27.9
 ;;^UTILITY(U,$J,358.3,2966,2)
 ;;=^5007154
 ;;^UTILITY(U,$J,358.3,2967,0)
 ;;=I27.0^^18^210^70
 ;;^UTILITY(U,$J,358.3,2967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2967,1,3,0)
 ;;=3^Pulmonary Hypertension,Primary
 ;;^UTILITY(U,$J,358.3,2967,1,4,0)
 ;;=4^I27.0
 ;;^UTILITY(U,$J,358.3,2967,2)
 ;;=^265310
 ;;^UTILITY(U,$J,358.3,2968,0)
 ;;=I73.00^^18^210^71
 ;;^UTILITY(U,$J,358.3,2968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2968,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,2968,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,2968,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,2969,0)
 ;;=R57.0^^18^210^72
 ;;^UTILITY(U,$J,358.3,2969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2969,1,3,0)
 ;;=3^Shock,Cardiogenic
 ;;^UTILITY(U,$J,358.3,2969,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,2969,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,2970,0)
 ;;=R57.1^^18^210^73
 ;;^UTILITY(U,$J,358.3,2970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2970,1,3,0)
 ;;=3^Shock,Hypovolemic
 ;;^UTILITY(U,$J,358.3,2970,1,4,0)
 ;;=4^R57.1
 ;;^UTILITY(U,$J,358.3,2970,2)
 ;;=^60845
 ;;^UTILITY(U,$J,358.3,2971,0)
 ;;=R57.9^^18^210^74
 ;;^UTILITY(U,$J,358.3,2971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2971,1,3,0)
 ;;=3^Shock,Unspec
 ;;^UTILITY(U,$J,358.3,2971,1,4,0)
 ;;=4^R57.9
 ;;^UTILITY(U,$J,358.3,2971,2)
 ;;=^5019527
 ;;^UTILITY(U,$J,358.3,2972,0)
 ;;=R55.^^18^210^75
 ;;^UTILITY(U,$J,358.3,2972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2972,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,2972,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,2972,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,2973,0)
 ;;=I78.0^^18^210^76
 ;;^UTILITY(U,$J,358.3,2973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2973,1,3,0)
 ;;=3^Telangiectasia,Hereditary Hemorrhagic
 ;;^UTILITY(U,$J,358.3,2973,1,4,0)
 ;;=4^I78.0
 ;;^UTILITY(U,$J,358.3,2973,2)
 ;;=^117566
 ;;^UTILITY(U,$J,358.3,2974,0)
 ;;=I73.1^^18^210^20
 ;;^UTILITY(U,$J,358.3,2974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2974,1,3,0)
 ;;=3^Buerger's Disease
 ;;^UTILITY(U,$J,358.3,2974,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,2974,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,2975,0)
 ;;=G45.9^^18^210^77
 ;;^UTILITY(U,$J,358.3,2975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2975,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,2975,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,2975,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,2976,0)
 ;;=G45.8^^18^210^78
